埃博拉病毒诊断试剂（刚果） 返回列表页

美国NovaBios埃博拉病毒诊断试剂（刚果）

广州健仑生物科技有限公司

本司长期供应埃博拉病毒检测试剂盒，其主要品牌包括美国NovaBios、广州创仑等CDC使用的进口产品，试剂盒的实验方法包括胶体金方法、ELISA方法、PCR方法等。

欢迎咨询

欢迎咨询2042552662

埃博拉病毒IgM、IgG、ELISA检测试剂、埃博拉快速检测试剂盒、

埃博拉病毒核酸检测试剂盒（荧光探针PCR）

西非工作、旅游埃博拉检测试剂盒

美国CDC使用的埃博拉诊断试剂——美国的NovaBios

美国NovaBios 埃博拉病毒诊断试剂（刚果）

【埃博拉简介】

埃博拉（Ebola virus）又译作伊波拉病毒。是一种十分罕见的病毒，1976年在苏丹南部和刚果（金）（旧称扎伊尔）的埃博拉河地区发现它的存在后，引起医学界的广泛关注和重视，“埃博拉”由此而得名。是一个用来称呼一群属于纤维病毒科埃博拉病毒属下数种病毒的通用术语。是一种能引起人类和灵长类动物产生埃博拉出血热的烈性传染病病毒，有很高的死亡率，在50%至90%之间，致死原因主要为中风、心肌梗塞、低血容量休克或多发性器官衰竭。

埃博拉出血热（EBHF）是由一种丝状病毒感染导致的急性出血性、动物源性传染病。1976年，埃博拉出血热在非洲的苏丹和扎伊尔暴发，病死率高达50% ～ 90% 。因该病始发于扎伊尔北部的埃博拉河流，并在该区域严重流行，故命名为埃博拉病毒，其形态学、致病性等与马尔堡病毒相似，但免疫原性有所区别。

【产品介绍】

该产品是世界卫生组织（WHO）*个批准用于埃博拉病毒检测的诊断试剂卡。不需要借助其他实验仪器设备，只需要采取几滴血清、血浆、血液样品，既可以检测，并在15分钟内就可以得知结果是否感染埃博拉病毒。该产品具有灵敏度高、操作方便、实验时间短等特点。

美国NovaBios

正在西非乃至 肆虐的埃博拉病毒，有着*的高致死率。在以往 的爆发中，高达90%的被感染者死于埃博拉。和本次大爆发同宗的扎伊尔型埃博拉病毒以往平均死亡率为80%。这也是为什么，世界卫生组织疫情报告中的数据看起来有那么一丁点像好消息—— 尽管埃博拉感染率正在以惊人的速度攀升，报告中整体死亡率却只有53%，从塞拉利昂的39%到几内亚的64%。这比以往几次疫情爆发要相对温和一点。难道是这次爆发的病毒比以往的致死率与危害性低一点?还是说我们已经有了更有效的治疗方案?
　　实际上此处有一个隐情：明显降低的死亡率可能更多是因为*测算方式的缘故，而非病毒的致死率，或者说患者接受的治疗水平导致的。事实上，zui近几周感染人数的急剧增加，正是报告死亡率看起来不那么高的其中一个主要原因。
　　*所谓的死亡率，或者说一个爆发疾病的“病死率”，有若干计算方式。其中zui为简单的，就是目前死亡人数除以目前总感染人数。世界卫生组织zui近报告的死亡率也就是这样计算的。
　　但是这种方法并没有考虑到，许多依然存活的病人——特别是刚刚被诊断又病得很厉害的——很可能也不能活下来。因此这低估了实际死亡率。特别是疾病在快速扩张时，这种低估效应会被加大。来自英国爱丁堡大学研究传染病的进化生物学家Andrew Rambaut认为，这种计算也忽视了那些被确诊为埃博拉感染者，却在被批准恢复并出院之前已经离开医院的患者的生死。许多这样的病人后来都死了，但是却没有被统计在*死亡数据中。
　　另一种计算方式是只考虑已经确认恢复而不再需要治疗与已经死于疾病的患者，而不计入目前还在治疗中的病人。这样的结果看起来更为克制精确。根据11月5号塞拉利昂健康与卫生部疫情报告，841个确诊病人被治疗后出院了，而1,103个确诊病人已经过世。这样该地的埃博拉死亡率应该是57%，而非世界卫生组织报告的39%。不过来自哈佛公共卫生学院的流行病学专家Marc Lipsitch认为，这样的计算方式依然不够准确。治愈出院的病人通常比死于病症的病人，要在医院待更长的时间。也就是说不计入计算的还在治疗中的病人，实际上是更可能治愈的那批。因此这样的计算会高估实际死亡率。

美国NovaBios

我司还提供其它进口或国产试剂盒：登革热、疟疾、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

想了解更多的NovaBios产品及服务请扫描下方二维码：

【公司名称】 广州健仑生物科技有限公司
【市场部】    杨永汉

【】 
【腾讯  】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

The Ebola virus, which is raging in West Africa and the world, has a well known high lethality. In the past, up to 90% of the infected people died in Ebola. And the outbreak of the same case of Zaire-type Ebola virus in the past the average mortality rate of 80%. That's why the data in the latest WHO report looks so good news - despite the fact that the Ebola infection rate is climbing at an alarming rate, the overall mortality rate in the report is only 53 per cent, from the Sierra Leone 39% to 64% of Guinea. This is relatively mild than the previous outbreak of the epidemic. Is it the outbreak of the virus than the previous lethality and harm lower? Or that we have a more effective treatment program?
In fact there is a hidden situation here: the apparent reduction in mortality may be more due to the official method of measurement, rather than the mortality rate of the virus, or the level of treatment received by the patient. In fact, the sharp increase in the number of infections in recent weeks is one of the main reasons for reporting that mortality is not so high.
The official so-called mortality rate, or an outbreak of the disease "mortality", there are a number of ways to calculate. One of the most simple is the current number of deaths divided by the current total number of infections. The World Health Organization's recently reported mortality rate is calculated as such.
But this approach does not take into account that many surviving patients - especially those who have just been diagnosed and ill - are likely to survive. So this underestimates the actual mortality rate. Especially in the rapid expansion of the disease, this underestimated effect will be increased. Andrew Rambaut, an evolutionary biologist at the University of Edinburgh who studies infectious diseases in the UK, believes that this calculation also ignores the life and death of patients who have been diagnosed with Ebola infection but who have left the hospital before being approved for recovery and discharge. Many of these patients were later dead, but they were not counted in official death data.
Another way is to consider only patients who have confirmed recovery and no longer need treatment and who have died of the disease, regardless of the patients who are still in the process of treatment. This result seems to be more restrained. According to the latest epidemic report of the Ministry of Health and Health in Sierra Leone on November 5, 841 confirmed patients were discharged after treatment and 1,103 confirmed patients had passed away. So that the Ebola death rate should be 57%, rather than 39% of the World Health Organization reported. However, from the Harvard School of Public Health epidemiologist Marc Lipsitch that this calculation is still not accurate enough. Cure patients are usually discharged longer than the patient who died of the illness and had to stay in the hospital for a longer period of time. That is, do not count into the calculation of the patients still in the treatment, in fact, is more likely to cure the batch. So this calculation will overestimate the actual mortality rate.